These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 10730393)

  • 1. [Our 3- to 5-year experience with Anteovin].
    Pŭnevska M; Veltova L; Vlasova D
    Akush Ginekol (Sofiia); 1999; 38(2):54-5. PubMed ID: 10730393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The use of the preparation Anteovin in dysfunctional uterine hemorrhages and PCOS].
    Kolarov G; Nalbanski B; Orbetsova M; Kamenov Z; Sirakov M; Filipov E
    Akush Ginekol (Sofiia); 1999; 38(3):32-5. PubMed ID: 10734678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Practical observations of the use of the contraceptive preparation Anteovin].
    Milchev N; Pekhlivanov B; Piperkov T
    Akush Ginekol (Sofiia); 1990; 29(6):88-90. PubMed ID: 2100964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined estradiol/gestodene and acute pancreatitis.
    Trenque-Tessereau MG; Picot C; Herment N; Trenque TC
    Ann Pharmacother; 2005 Nov; 39(11):1953-4. PubMed ID: 16204389
    [No Abstract]   [Full Text] [Related]  

  • 5. Observations with anteovin in dermatological disorders.
    Vánkos J
    Ther Hung; 1986; 34(4):204-11. PubMed ID: 2966994
    [No Abstract]   [Full Text] [Related]  

  • 6. A clinical study of transdermal contraceptive patch in Thai adolescence women.
    Piyasirisilp R; Taneepanichskul S
    J Med Assoc Thai; 2008 Feb; 91(2):137-41. PubMed ID: 18389975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mood and physical symptoms improve in women with severe cyclical changes by taking an oral contraceptive containing 250-mcg norgestimate and 35-mcg ethinyl estradiol.
    Nyberg S
    Contraception; 2013 Jun; 87(6):773-81. PubMed ID: 23121822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Examinations with Anteovin, a biphasic contraceptive.
    Adám J; Garamvölgyi G
    Ther Hung; 1984; 32(4):176-80. PubMed ID: 6571205
    [No Abstract]   [Full Text] [Related]  

  • 9. Oral contraceptive-induced central retinal artery occlusion.
    Rekhi GS; Dheer S
    J Assoc Physicians India; 2002 Aug; 50():1084-5. PubMed ID: 12421041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral contraception with a biphasic tablet (observations with anteovin).
    Tallián F
    Ther Hung; 1986; 34(2):112-6. PubMed ID: 3449970
    [No Abstract]   [Full Text] [Related]  

  • 11. Less estrogen in new oral contraceptive.
    Am J Nurs; 2003 Apr; 103(4):111-2. PubMed ID: 12677126
    [No Abstract]   [Full Text] [Related]  

  • 12. [Changes in the concentration of individual proteins in women using current peroral contraceptives].
    Ulichkova E; Malinova M; Pekhlivanov B; Sirakova I
    Akush Ginekol (Sofiia); 1999; 38(2):27-9. PubMed ID: 10730381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of a new 24-day oral contraceptive regimen of norethindrone acetate 1 mg/ethinyl estradiol 20 micro g (Loestrin 24 Fe).
    Nakajima ST; Archer DF; Ellman H
    Contraception; 2007 Jan; 75(1):16-22. PubMed ID: 17161118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lybrel--a continuous oral contraceptive.
    Med Lett Drugs Ther; 2007 Jul; 49(1266):61-2. PubMed ID: 17652998
    [No Abstract]   [Full Text] [Related]  

  • 15. Use of biphasic cyclic hormone therapy in functional bleeding disorders of adolescents (Anteovin).
    Kis-Csitári I
    Ther Hung; 1988; 36(2):73-6. PubMed ID: 3201389
    [No Abstract]   [Full Text] [Related]  

  • 16. Triphasil--a new triphasic oral contraceptive.
    Med Lett Drugs Ther; 1985 May; 27(688):48. PubMed ID: 4000059
    [No Abstract]   [Full Text] [Related]  

  • 17. Long-term safety of an extended-cycle oral contraceptive (Seasonale): a 2-year multicenter open-label extension trial.
    Anderson FD; Gibbons W; Portman D
    Am J Obstet Gynecol; 2006 Jul; 195(1):92-6. PubMed ID: 16813747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of menstrual disorders with a combination of norgestrel and ethynyl estradiol.
    Rao KP
    Curr Med Pract; 1971; 15(1):586-9. PubMed ID: 12306340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Minisiston as a contraceptive for adolescents].
    Havlín M
    Ceska Gynekol; 1997 Dec; 62 Suppl():19-20. PubMed ID: 9601711
    [No Abstract]   [Full Text] [Related]  

  • 20. Oral contraceptives: a cause of hyperbilirubinemia in stem cell transplant patients.
    Kline RM; Fennewald L; Vore M; Bertolone SJ; Hente ML
    J Pediatr Hematol Oncol; 1999; 21(5):436-40. PubMed ID: 10524461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.